Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors

Chemistry and Physics of Lipids
Yoshikazu Uto

Abstract

Stearoyl-CoA desaturase 1 (SCD1) is a rate-limiting enzyme in the biosynthesis of monounsaturated fatty acids from their saturated fatty acid precursors. SCD1 introduces a cis-double bond at the Δ9 position (between carbons 9 and 10) of stearoyl (C18:0) and palmitoyl-CoA (C16:0). SCD1 has been shown to be a crucial factor in lipid metabolism and body weight control. In addition, SCD1 inhibitors are claimed to be new treatments for various diseases, such as skin disorders, nonalcoholic steatohepatitis (NASH), hepatitis C virus (HCV), Alzheimer's disease, or cancer. This review aims to summarize the examples of the recently reported novel SCD1 inhibitors and to highlight the emerging areas of target indications that may hold promise for the development of SCD1 inhibitors.

References

Jan 1, 1995·Progress in Lipid Research·J M Ntambi
May 1, 1994·International Journal of Cancer. Journal International Du Cancer·J LiR S Gilmour
Jun 15, 2000·The American Journal of Pathology·J P SundbergK Stenn
Apr 19, 2002·The New England Journal of Medicine·Paul Angulo
Sep 6, 2002·The New England Journal of Medicine·J Christian Bode
Mar 21, 2003·Biochemical and Biophysical Research Communications·Shigeko UryuTomiichiro Oda
Nov 24, 2004·Clinics in Dermatology·Christos C Zouboulis
May 24, 2005·Biochemical and Biophysical Research Communications·Jian WangGuoqing Cao
Nov 9, 2005·The Journal of Biological Chemistry·Weng Chi ManJames M Ntambi
Jan 12, 2007·British Journal of Clinical Pharmacology·Anick BérardDriss Oraichi
May 29, 2007·Journal of Medicinal Chemistry·Gang LiuHeidi S Camp
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brian I Rini
May 8, 2008·Current Opinion in Lipidology·Matthew T Flowers, James M Ntambi
Jul 18, 2008·Bioorganic & Medicinal Chemistry Letters·Zhili XinGang Liu
Apr 3, 2009·Biochemical and Biophysical Research Communications·Makoto MiyazakiJames M Ntambi
Aug 21, 2009·Expert Opinion on Therapeutic Patents·Gang Liu
Oct 8, 2009·The Journal of Biological Chemistry·Hervé LeratJean-Michel Pawlotsky
Dec 17, 2009·Bioorganic & Medicinal Chemistry Letters·Serge LégerLei Zhang
Feb 9, 2010·Bioorganic & Medicinal Chemistry Letters·Yeeman K RamtohulChun Sing Li
Apr 27, 2010·Clinical Oncology : a Journal of the Royal College of Radiologists·R C Smallridge, J A Copland
Nov 3, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Herbert Tilg, Alexander R Moschen
Apr 19, 2011·Trends in Endocrinology and Metabolism : TEM·Eva Herker, Melanie Ott
May 20, 2011·RNA Biology·Gualtiero AlvisiRalf Bartenschlager
Jun 10, 2011·Advances in Anatomic Pathology·Fatima Zahra Aly, David E Kleiner
Sep 2, 2011·Current Opinion in Cell Biology·Ramiro Iglesias-Bartolome, J Silvio Gutkind
Sep 29, 2011·Molecular Cancer Research : MCR·Urvashi V RoongtaBrent A Rupnow
Nov 3, 2011·PloS One·Giuseppe AstaritaDaniele Piomelli
Dec 3, 2011·The Journal of Biological Chemistry·Robin B ChanGilbert Di Paolo
Sep 18, 2012·Current Drug Metabolism·Michel NarceSandrine Bellenger
Dec 5, 2012·Breast Cancer Research and Treatment·Ashley M HolderFunda Meric-Bernstam
Mar 1, 2013·Nature Reviews. Cancer·Arkaitz CarracedoPier Paolo Pandolfi
Mar 1, 2013·The Journal of Investigative Dermatology·Josef G MeingassnerAndreas Billich

❮ Previous
Next ❯

Citations

Aug 24, 2016·Biochimica Et Biophysica Acta·Andreas KoeberleMaria Thürmer
Mar 3, 2017·Journal of Medicinal Chemistry·Ewgenij ProschakDaniel Merk
Mar 30, 2018·American Journal of Clinical Dermatology·Megha K TrivediLarissa N Larsen
Dec 27, 2018·Cellular Microbiology·Alberto Fernández-OlivaCristina Risco
Jan 26, 2016·Oncogenesis·S Beloribi-DjefafliaF Guillaumond
Feb 26, 2020·The Journal of Experimental Medicine·Jeroen F J BogieJerome J A Hendriks
Oct 31, 2019·Journal of Medicinal Food·Abril Ramírez-HigueraRosa María Oliart-Ros
Sep 28, 2018·Chemical Science·Lauren E JamiesonDuncan Graham
Jul 25, 2019·Frontiers in Immunology·Katharina A MayerGuido A Gualdoni
Aug 1, 2019·Hepatology International·Joseph J Alukal, Paul J Thuluvath
Nov 20, 2020·International Journal of Molecular Sciences·Lucas M O'NeillJames M Ntambi
May 20, 2020·Biochemical and Biophysical Research Communications·Lucas M O'NeillJames M Ntambi
May 5, 2021·Developmental Cell·Lindsay A BroadfieldSarah-Maria Fendt
Jul 21, 2021·Nutrition and Cancer·Eric Francisco Contreras-LópezRosa María Oliart-Ros
Aug 8, 2021·International Journal of Molecular Sciences·Aida V Garcia CorralesJerome J A Hendriks

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.